Our Research Advisory Panel is made up of a number of experts in the field of childhood cancer. They are independent of our board of Trustees and the members come from a number of different institutions and have a number of varied specialisms. This is to help ensure that decisions are well informed and impartial when they are made. The panel also includes at least one expert parent reviewer whenever possible.

What does the Research Advisory Panel Do?

The panel is made up individuals who give their time and expertise on a purely voluntary basis. We are exceptionally grateful to these volunteers for helping us to ensure high quality research recommendations are made to the Board of Trustees.

It is through these recommendations that the Trustees at the Grace Kelly Childhood Cancer Trust can be sure that they are helping to fund research of the highest possible quality. This is so important.

How we award research funding  

Research Advisory Panel conflicts of interest

Research Advisory Panel code of conduct

Professor Bernadette Brennan, Consultant Paediatric Oncologist and Chair of the RAP

Professor Bernadette Brennan is elected Chair of the GKCCT Research Advisory Panel and the MAHSC Honorary Clinical Chair in Paediatric Oncology at Royal Manchester Children’s Hospital UK; MAHSC Honorary Clinical Chair in Paediatric Oncology; Consultant Paediatric Oncologist and Honorary Consultant Paediatric Oncologist at The Christie NHS Trust and Associate Director of Research and Innovation (Governance) for Manchester University Foundation Trust.

Paediatric Cancer Services E04 CRG/NHS England Commissioning –Greater Manchester, Lancashire and South Cumbria Senate Rep, Greater Manchester Cancer -Clinical Director for Children’s pathway -for the Manchester Cancer Services Provider Board, Chair NCRI Sarcoma CSG.

Dr Stephen Lowis, Consultant Paediatric Oncologist

Dr Lowis is a MacMillan Consultant in Paediatric and Adolescent Oncology at Bristol Royal Hospital for Children. He is a former Chair of the CCLG Special Interest Group for Neuro- oncology and of the RCPCH Oncology Special Advisory Committee. He will be the Chief Investigator for the forthcoming ATRT 01 study.

He has a particular interest in neuro-oncology, pharmacology, new drug development and pharmacokinetics.


Dr Martin Elliott, Consultant Paediatric Oncologist

Dr Martin Elliott, paediatric oncologist Leeds Teaching Hospitals since 2004 and in my post I treat children and teenagers with all types of solid tumours including brain tumours.

My clinical research interest is in neuroblastoma and I am the UK chief investigator of a major European clinical trial for patients with high-risk neuroblastoma SIOPEN HR-NBL2.  I lead the Leeds Children’s Hospital NIHR / CRUK funded Experimental Cancer Medicine Centre and have recently been appointed as the NIHR Clinical Research Network, National Specialty Lead for Children and Young People’s Cancer.

I am committed to conducting and promoting high quality research in paediatric oncology to improve outcomes for affected children and their families.

Dr Mette Jorgensen, Consultant Paediatric Oncologist

Dr Mette Jorgensen, MD PhD MRCPCH graduated from Aarhus University, Denmark. She did her post graduate paediatric oncology training in the UK (London). Mette works as a Consultant Paediatric Oncologist at Great Ormond Street Hospital. She is the lead for neuro-oncology (children with brain tumours) and Genetic Oncology (cancer predisposition syndromes).

She has a special interest in sarcoma and rare tumours. She has a PhD from UCL in cancer genetics, gene therapy and molecular biology. She is married and has two teenage boys.

Dr Laura Roe, Consultant Paediatrician

I am a consultant paediatrician with a special interest in oncology and palliative care. I have been a consultant for 5 years working at Staffordshire Children’s Hospital at Royal Stoke and The Donna Louise Children’s Hospice.

I consider my job a privilege, getting the opportunity to work with incredible children and their families. I am passionate about supporting work that can offer support and improved treatment options to the children I care for.


Dr Kate Bishop

Dr Kate Bishop and my current role is the Director of Operations for the College of Medical and Dental Sciences at the University of Birmingham.  My role includes overseeing the operations of the College, across our research (annual research awards £80m) and teaching (7000 undergraduate and postgraduate students) activities. 

I have a background in medical research having completed my PhD in liver research at the University of Birmingham, following a BSc in Biochemistry.  Following my PhD I moved into research management and development, having a variety of roles including leading the grant application support service across the University of Birmingham, working as a panel secretary for the Research Excellence and working on a regional investment fund focussed on medical technologies. I am a mother of two young girls, an avid horse rider and keen runner.  I am really looking forward to supporting the Grace Kelly Childhood Cancer Trust to take forward their research strategy and enable important research to happen.

Dr Marie Cohen, General Practitioner and parent expert

The GKCCT helped my family hugely when my younger daughter was diagnosed with cancer in 2019 – the leaflets were so helpful in making sure that she could understand what was happening and get as involved as possible.

I’m now back at work as a GP in North Yorkshire and determined to raise awareness of childhood cancer amongst my colleagues. I also have a special interest in palliative care.


Dr Louise Chapman, Senior training scientist and parent expert

I am currently working as a senior training scientist in one of the government Covid testing laboratories, but my scientific background is in immunology. I completed my PhD and worked on several research grants as a post-doc at the University of Manchester where our main area of interest was gut inflammation.

In 2017 my daughter Molly, almost 6, was diagnosed with a malignant rhabdoid tumour in her neck. She underwent aggressive chemotherapy and proton beam therapy and is thankfully now a thriving 10 year-old. We were supported throughout Molly’s treatment by the GKCCT and have since been committed to helping this amazing charity in any way we can.

We have a named fund ‘Molly’s Way’ and I am honoured to have been asked to take up this role within the committee.

Dr Olga Slater, Consultant Paediatric Oncologist

Olga is Consultant Paediatric Oncologist at Great Ormond Street Hospital in London. She undertook her undergraduate degree in Medicine in Zagreb, Croatia. Her training in paediatric and paediatric oncology was conducted in London and South East. She completed PhD in Innovative therapies in rhabdomyosarcoma at the ICR and University of London. She has special interest in sarcoma and rare tumours, especially in infants. Olga lives in Kent with her husband and has two daughters.